Physician

David Patrick Kennedy, M.D.

According to 2025 Medicare claims, David Kennedy, M.D. (NPI: 1518258755) practices ophthalmology in the New Orleans-Metairie, LA market, with the plurality of this provider's patient population coming from Jefferson, LA. This provider's primary affiliated billing organization is GULF SOUTH EYE ASSOCIATES APMC (NPI: 1548227986; TIN: 72-1076001) and primary practice location at 70006-2934.

Kennedy's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 667 traditional Medicare patients, billed 1,824 HCPCS/CPT codes, and received $166,515 in Medicare payments. The top billing code was 92014 (Established patient complete exam of visual system). Part D data shows 2,826 prescription claims across 660 beneficiaries totaling $756,876 in drug costs, led by Restasis (Cyclosporine). Open Payments data shows 54 records totaling $1,124. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $16,822 to $166,515. Similarly, Part D prescription costs have moved sharply higher in recent years, from $39,770 to $756,876. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$83K$167K2015 Medicare payment: $16,822 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $43,945 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $67,963 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $84,827 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $105,207 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $72,074 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $122,300 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $145,333 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $150,337 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $166,515 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
2015165270$16,822
2016229509$43,945
2017273768$67,963
2018294854$84,827
20193431,030$105,207
2020309781$72,074
20214441,296$122,300
20226701,710$145,333
20236311,719$150,337
20246671,824$166,515

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$378K$757K2015 Drug cost: $39,770 (USD; Tot_Drug_Cst)2016 Drug cost: $52,126 (USD; Tot_Drug_Cst)2017 Drug cost: $88,184 (USD; Tot_Drug_Cst)2018 Drug cost: $102,126 (USD; Tot_Drug_Cst)2019 Drug cost: $322,250 (USD; Tot_Drug_Cst)2020 Drug cost: $188,647 (USD; Tot_Drug_Cst)2021 Drug cost: $201,751 (USD; Tot_Drug_Cst)2022 Drug cost: $238,061 (USD; Tot_Drug_Cst)2023 Drug cost: $235,185 (USD; Tot_Drug_Cst)2024 Drug cost: $756,876 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015174528$39,770
2016181513$52,126
2017233825$88,184
20183141,110$102,126
20194281,617$322,250
20203991,368$188,647
20215292,023$201,751
20226182,640$238,061
20236412,613$235,185
20246602,826$756,876

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
92014Established patient complete exam of visual system399399$82
99213Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more230436$65
92083Exam of visual field with extended testing9099$44
92134Imaging of retina131154$28
92133Imaging of optic nerve105110$24

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
RestasisCyclosporine1235,190$102,543
XdemvyLotilaner15638$28,652
XiidraLifitegrast321,140$26,118
LumiganBimatoprost582,557$25,865
Prednisolone AcetatePrednisolone Acetate56215,479$18,444

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.54$1,124RxSight Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for David Patrick Kennedy, M.D.?

Tedicare shows public-source Medicare data for David Patrick Kennedy, M.D. (NPI 1518258755), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does David Patrick Kennedy, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to David Patrick Kennedy, M.D.?

David Patrick Kennedy, M.D. is linked to GULF SOUTH EYE ASSOCIATES APMC (billing NPI 1548227986) in the available physician profile data.

Does David Patrick Kennedy, M.D. have Open Payments data?

David Patrick Kennedy, M.D. has 54 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.